Add BrightSurf on Google Email

Science News Archive June 2006 - Page 15


Page 15 of 16

Men face rising osteoporosis risk

Rates of hip bone loss increase with age among white and non-white men, particularly those over 75. Osteoporosis in men results from declining estrogen levels, leading to brittle bones prone to fracture. The study predicts a 56% increase in male osteoporotic fractures and associated costs by 2025.

SourceInternational Osteoporosis Foundation·JournalOsteoporosis International·DateJun 4, 2006

Liquorice cancer care

Studies have shown that glycerrhetinic acid and glycerrhizic acid, found in liquorice, preferentially accumulate in the liver and can target tumors effectively. This could lead to improved treatment outcomes with reduced toxic effects on other parts of the body.

SourceSociety of Chemical Industry·JournalPolymer International·DateJun 4, 2006

Where climate is made in a greenhouse world

Researchers identify a previously unrecognized link between mid-latitude climate dynamics and tropical African climate, leading to exceptionally high organic carbon burial. The study suggests that changes in atmospheric pressure systems and surface winds drive variations in precipitation and runoff patterns.

SourceNewcastle University·JournalPaleoceanography·DateJun 1, 2006

Highlights from the June 2006 Journal of the American Dietetic Association

A survey found that many people do not look at food labels or understand the calorie information they contain, which may limit the effectiveness of nutrition labeling legislation in combating obesity. A high-fiber diet was also found to be associated with normal body fat stores and standard weight for height in adults.

SourceAmerican Dietetic Association·JournalJournal of the American Dietetic Association·DateJun 1, 2006

Combination therapy shows promising results in patients with advanced lung cancer

Researchers have found that pairing Tarceva with Celebrex significantly increases response rates in lung cancer patients, offering a potential breakthrough in treating the disease. The combination therapy has shown to increase response rates by about three-fold, with some patients experiencing responses for up to 93 weeks.

SourceUniversity of California - Los Angeles·JournalClinical Cancer Research·DateJun 1, 2006